Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
US4601903A · kind A · utility
196Cited by
3References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 1, 1985 |
| Grant date | Jul 22, 1986 |
| Priority date | — |
| Expiry date | May 1, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/095
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses a vaccine against Neisseria meningitidis Group B, serotype 2b strain. More particularly, the present invention is related to an aluminum hydroxide adjuvanted vaccine containing only a single serotype 2 antigen being protective against both 2a and 2b meningococcal disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.